Artikel ; Online: A multi-genotype therapeutic human papillomavirus vaccine elicits potent T cell responses to conserved regions of early proteins.
2019 Band 9, Heft 1, Seite(n) 18713
Abstract: Despite an efficacious prophylactic human papillomavirus (HPV) vaccine there is still a considerable global burden of HPV-related disease. Therapeutic vaccines that could prevent cancers in at-risk women are urgently needed. Most candidate therapeutic ... ...
| Abstract | Despite an efficacious prophylactic human papillomavirus (HPV) vaccine there is still a considerable global burden of HPV-related disease. Therapeutic vaccines that could prevent cancers in at-risk women are urgently needed. Most candidate therapeutic vaccines have focused on two high-risk (hr) HPV genotypes, 16 and 18, and two viral targets, E6 and E7, which may limit global coverage and efficacy. We designed the synthetic gene '5GHPV3' by selecting conserved regions from each of the six early proteins and generating consensus sequences to represent five hrHPV genotypes. 5GHPV3 was delivered by plasmid DNA, chimpanzee adenovirus (ChAdOx1) and modified vaccinia Ankara (MVA) vectors in prime-boost regimens to mice. ChAdOx1-5GHPV3 / MVA-5GHPV3 induced higher magnitude and more durable HPV-specific T cell responses than other regimens. Vaccine-induced T cells were polyfunctional and persisted at high frequencies for at least six weeks. Importantly, HPV-specific effector CD8 + T cells were detected in the cervix following systemic administration of ChAdOx1-5GHPV3 / MVA-5GHPV3 and increased in frequency over time, indicating continued trafficking of T cells to the cervix. Finally, T cells specific for 5GHPV3 encoded antigens were detected by IFN-γ Elispot in women with current or past hrHPV infections, confirming the presence of epitopes relevant to natural immune control. |
|---|---|
| Mesh-Begriff(e) | Adolescent ; Adult ; Animals ; CD8-Positive T-Lymphocytes/immunology ; Female ; Genetic Vectors ; Genotype ; Humans ; Immunization, Secondary ; Mice ; Mice, Inbred C57BL ; Middle Aged ; Oncogene Proteins, Viral/genetics ; Papillomaviridae/genetics ; Papillomaviridae/immunology ; Papillomavirus Infections/immunology ; Papillomavirus Infections/metabolism ; Papillomavirus Vaccines/genetics ; Papillomavirus Vaccines/immunology ; Vaccination ; Vaccines, DNA/genetics ; Vaccines, DNA/immunology |
| Chemische Substanzen | Oncogene Proteins, Viral ; Papillomavirus Vaccines ; Vaccines, DNA |
| Sprache | Englisch |
| Erscheinungsdatum | 2019-12-10 |
| Erscheinungsland | England |
| Dokumenttyp | Journal Article |
| ZDB-ID | 2615211-3 |
| ISSN | 2045-2322 ; 2045-2322 |
| ISSN (online) | 2045-2322 |
| ISSN | 2045-2322 |
| DOI | 10.1038/s41598-019-55014-z |
| Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.